Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06596785

Risk Factors and Deep Learning Model for CI-AKI

Investigation and Early Risk Prediction of Acute Kidney Injury Caused by Iodinated Contrast Agents: Development of CI-AKIDPi Model Based on Interpretable Deep Learning

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
2,000 (actual)
Sponsor
Xiao Li,MD · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent.

Detailed description

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent. Despite the frequent use of iodinated contrast agents in medical investigations, predictive models for CI-AKI are scarce. This study aimed to construct and validate interpretable deep learning models for the early risk prediction of acute kidney injury (AKI) associated with iodinated contrast agents.

Conditions

Timeline

Start date
2024-06-01
Primary completion
2025-03-01
Completion
2025-06-01
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06596785. Inclusion in this directory is not an endorsement.